期刊文献+

肿瘤内改变在局限性肾透明细胞癌预后中的作用 被引量:3

Prognostic value of intratumoral changes for surgical treated localized clear cell renal cell carcinoma
下载PDF
导出
摘要 目的探讨肿瘤内改变在局限性肾透明细胞癌术后预后中的作用。方法回顾性分析手术治疗的283例肾透明细胞癌患者的临床病理特征,包括性别、年龄、平均体质指数、肿瘤内出血、肿瘤内坏死、肿瘤内囊性变、肿瘤肉瘤样变、Fuhrman分级、T分期等,并对其进行随访,获取无瘤生存时间及癌症特异性生存时间,通过单因素及多因素分析,得出影响肾透明细胞癌预后的因素。结果单因素发现,年龄、平均体质指数、肿瘤内出血、肿瘤内坏死、肿瘤肉瘤样变、Fuhrman分级、T分期是影响无复发生存的预后因素,年龄、平均体质指数、瘤内坏死、肿瘤肉瘤样变、Fuhrman分级、T分期是影响癌症特异性生存的预后因素。多因素分析发现,年龄、平均体质指数、肿瘤内坏死、肿瘤肉瘤样变、Fuhrman分级、T分期是影响肾透明细胞癌患者无复发生存及癌症特异性生存的独立预后因子。结论对于接受手术治疗的局限性肾透明细胞癌患者,肿瘤内改变如坏死、肉瘤样变是影响预后的独立因素。 Objective To investigate the prognostic value of intratumoral changes,such as bleeding,necrosis,cystic degeneration and sarcomatoid change,in surgical treated localized clear cell renal cell carcinoma.Method 283 patients receiving partial or radical nephrectomy between Jan 2008 and Jan 2013 in our department were retrospectively revised.Data such as gender,age,BMI,intratumoral changes,Fuhrman grade and T stage were collected,follow ups were carried out to get the recurrence-free survival and cancer-specific survival.Univariate and multivariate analysis were used to recognize the prognostic factors.Result Univariate analysis revealed that,age,BMI,intratumoral hemorrhage,tumor necrosis,sarcomatoid change,Fuhrman Grade and T stage were prognostic factors for recurrence-free survival,meanwhile,age,BMI,tumor necrosis,sarcomatoid change,Fuhrman Grade and T stage prognostic are the factors for cancer-specific survival.Multivariate analysis revealed that,tumor necrosis,sarcomatoid change,as well as age,BMI,Fuhrman Grade and T stage were independent prognostic factors for recurrence-free survival and cancerspecific survival.Conclusion Intratumoral changes,such as tumor necrosis and sarcomatoid change are independent prognostic factors affecting recurrence-free survival and cancer-specific survival for surgical treated localized clear cell renal cell carcinoma.
作者 孙凤岭 滕竞飞 关亚伟 贾卓敏 高峰 李志辉 艾星 SUN Feng-ling TENG Jing-fei GUAN Ya-wei JIA Zhuo-min GAO Feng LI Zhi-hui AI Xing(Department of Urology, PLA Army General Hospital, Beijing 100700, China)
出处 《中国临床医生杂志》 2016年第12期55-60,共6页 Chinese Journal For Clinicians
关键词 肾透明细胞癌 坏死 肉瘤样变 预后 Clear cell renal cell carcinoma Necrosis Sarcomatoid changes Prognostic
  • 相关文献

参考文献3

二级参考文献43

  • 1Motzer RJ,Russo P.Systemic therapy for renal cell carcinoma[J].J Urol,2000,163:408-417. 被引量:1
  • 2Stadler WM,Huo D,George C,et al.Prognostic factors for survival with gemctabine plus 5-fluouracil based regimens for metastasis renal cell cancer[J].J Urol,2003,170:1141 -1145. 被引量:1
  • 3Oevermann K,Buer J,Hoffmann R,et al.Capecitabine in the treatment of metastasis renal cell carcinoma[J].Brit J Cancer,2000,83:583-587. 被引量:1
  • 4Negrier S,Escudier B,Lasset C,et al.Recombinant human interleukin -2,Recombinant human interferon -alfa -2a,or both in metastatic renal cell carcinoma[J].N Engl J Med,1998,338:1272 -1278. 被引量:1
  • 5Atzpodien J,Kirchner H,Hanninen El,et al.Interleukin -2 in combination with interferon-alpha and 5-fluorouracil for metastatic rehal cell cancer[J].Eru J Cancer,1993,29A(Suppl 5):S6 -S8. 被引量:1
  • 6Van-Herpen CM,Jansen RL,Kruit WH,et al.Immunotherapy with interleukin-2,interferon-alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma; a multi center phase Ⅱ study.Dutch Immunotherapy Woring Party[J].Br J Cancer,2000,82:772-776. 被引量:1
  • 7Dhodapkar MV,Steinman RM,Krasovsky J,et al.Antigen -specific inhibition T cell function in human after injection of immature dendritic cells[J].J Exo Med,2001,193:233 -238. 被引量:1
  • 8Steffens MG,Boerman OC,De Mulder PH,et al.Phase 1 radioimmunotherapy of metastatic renal cell carcinoma with Ⅰ-labeled chimeric monoclonal antibody G250[J].Clin Cancer Res,1999,5 (Suppl 10):3268s -3274s. 被引量:1
  • 9Bleumer I,Knuth A,Oosterwijk E,et al.A phase Ⅱ trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients[J].Br J Cancer,2004,90:985 -990. 被引量:1
  • 10Yang JC,Haworth L,Sherry RM,et al.A randomized trial of bevacizumab.An anti-vascular endothelial growth factor antibody.For metastatic renal cell cancer[J].New Engl J Med,2003,349:427-434. 被引量:1

共引文献23

同被引文献12

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部